Bronchial disorder
MONDO:0001358A disease involving the bronchus.
Also known as: bronchial disorder, bronchospasm, bronchus disease, bronchus disease or disorder, disease of bronchus, disease or disorder of bronchus, disorder of bronchus
1010 clinical trials for this condition and its sub-types, 19 tagged with Bronchial disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Bronchial disorder
-
Asthma 724 trials · 819 incl. sub-types
8 sub-types
- Chronic asthma 114 trials · 156 incl. sub-types Sub-types →
- Childhood onset asthma 111 trials
- Allergic asthma 41 trials Sub-types →
- Acute asthma 39 trials · 40 incl. sub-types Sub-types →
- Status asthmaticus 26 trials
- Intrinsic asthma 4 trials · 12 incl. sub-types Sub-types →
- Cough variant asthma 3 trials
- Occupational asthma 3 trials
-
Bronchiectasis 118 trials · 119 incl. sub-types
1 sub-type
- Idiopathic bronchiectasis 3 trials Sub-types →
-
Bronchitis 24 trials · 50 incl. sub-types
2 sub-types
- Chronic bronchitis 23 trials
- Croup 5 trials
-
Bronchial neoplasm 20 trials · 38 incl. sub-types
5 sub-types
- Bronchus cancer 3 trials · 26 incl. sub-types Sub-types →
- Bronchial endocrine tumor 4 trials
- Bronchus adenoma 0 trials Sub-types →
- Endobronchial leiomyoma 0 trials
- Endobronchial lipoma 0 trials
-
Non-syndromic bridging bronchus 0 trials
Most studied deeper sub-types
-
New asthma drug verekitug tested for Long-Term safety
Disease control OngoingThis study is for adults with severe asthma who finished the earlier VALIANT trial. It tests the long-term safety and effectiveness of verekitug, a drug given as a shot. About 396 people are taking part. The main goal is to see if verekitug is safe over time and if it can reduce …
Phase 2 • Sponsor: Upstream Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New asthma drug WIN378 aims to calm lung inflammation in phase 2 trial
Disease control OngoingThis study tests a new medicine, WIN378, for adults with moderate or severe asthma. WIN378 blocks a protein that causes lung inflammation, which may improve asthma control. About 136 participants will receive either WIN378 or a placebo to check safety, how the drug works in the b…
Phase 2 • Sponsor: Windward Bio • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC